Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants

Phase 3

Completed

Conditions: Pneumococcal Disease

Interventions: Biological: 13-valent pneumococcal conjugate vaccine
Biological: 20-valent pneumococcal conjugate vaccine

First Posted Date: 2020-08-28

Last Posted Date: 2023-04-21

Lead Sponsor: Pfizer

Target Recruit Count: 668

Registration Number: NCT04530838

Locations: 🇯🇵
NHO Nagoya Medical Center, Nagoya-shi, Aichi, Japan
🇯🇵
TOYOTA Memorial Hospital, Toyota-shi, Aichi, Japan
🇯🇵
Tsubaki Children's Clinic, Chiba-shi, Chiba, Japan

and more 35 locations

Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age

Phase 3

Completed

Conditions: Pneumococcal Disease

Interventions: Biological: Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)
Other: Saline
Biological: Influenza vaccine

First Posted Date: 2020-08-26

Last Posted Date: 2022-07-08

Lead Sponsor: Pfizer

Target Recruit Count: 1796

Registration Number: NCT04526574

Locations: 🇺🇸
Alliance for Multispecialty Research, LLC, New Orleans, Louisiana, United States
🇺🇸
East Valley Gastroenterology and Hepatology Associates, Chandler, Arizona, United States
🇺🇸
Hope Research Institute, Phoenix, Arizona, United States

and more 50 locations

Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice

Completed

Conditions: Psoriatic Arthritis

First Posted Date: 2020-08-18

Last Posted Date: 2024-10-10

Lead Sponsor: Pfizer

Target Recruit Count: 116

Registration Number: NCT04517669

Locations: 🇧🇪
Algemeen Stedelijk Ziekenhuis, Aalst, Belgium
🇧🇪
AZ Sint-Jan, Brugge, Belgium
🇧🇪
Nova Reuma Społka Partnerska, Genk, Belgium

and more 47 locations

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

Phase 2

Terminated

Conditions: Alopecia Areata

Interventions: Drug: PF-06651600
Drug: Placebo

First Posted Date: 2020-08-18

Last Posted Date: 2024-06-18

Lead Sponsor: Pfizer

Target Recruit Count: 71

Registration Number: NCT04517864

Locations: 🇺🇸
Marvel Clinical Research 002, LLC, Huntington Beach, California, United States
🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸
Skin Care Research, LLC, Hollywood, Florida, United States

and more 36 locations

A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)

Phase 2

Completed

Conditions: Hyperlipidemias
Dyslipidemias
Hyperlipoproteinemias

Interventions: Drug: Placebo
Drug: Vupanorsen

First Posted Date: 2020-08-18

Last Posted Date: 2022-10-04

Lead Sponsor: Pfizer

Target Recruit Count: 286

Registration Number: NCT04516291

Locations: 🇺🇸
Horizon Clinical Research Associates, PLLC, Gilbert, Arizona, United States
🇺🇸
Scottsdale Medical Imaging Research, LLC, Gilbert, Arizona, United States
🇺🇸
CARTI, Little Rock, Arkansas, United States

and more 109 locations

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

Phase 4

Completed

Conditions: Metastatic Non Small Cell Lung Cancer

Interventions: Drug: Dacomitinib

First Posted Date: 2020-08-13

Last Posted Date: 2024-04-05

Lead Sponsor: Pfizer

Target Recruit Count: 101

Registration Number: NCT04511533

Locations: 🇮🇳
Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi, India
🇮🇳
The Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
🇮🇳
Hemato Oncology Clinic Ahmedabad Pvt. Ltd, Ahmedabad, Gujarat, India

and more 12 locations

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

Completed

Conditions: Ankylosing Spondylitis

Interventions: Drug: Etanercept

First Posted Date: 2020-08-11

Last Posted Date: 2021-10-28

Lead Sponsor: Pfizer

Target Recruit Count: 763

Registration Number: NCT04507763

Locations: 🇮🇶
Pfizer, Baghdad, Iraq

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

Completed

Conditions: Spondyloarthrosis

Interventions: Drug: Etanercept

First Posted Date: 2020-08-11

Last Posted Date: 2021-10-04

Lead Sponsor: Pfizer

Target Recruit Count: 763

Registration Number: NCT04507776

Locations: 🇮🇶
Pfizer, Baghdad, Iraq

A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis

Phase 3

Terminated

Conditions: Atopic Dermatitis

Interventions: Drug: Crisaborole 2%

First Posted Date: 2020-08-04

Last Posted Date: 2021-08-12

Lead Sponsor: Pfizer

Target Recruit Count: 40

Registration Number: NCT04498403

Locations: 🇯🇵
Shirao Clinic of Pediatrics and Pediatric Allergy, Hiroshima-shi, Hiroshima, Japan
🇯🇵
Chitose dermatology and plastic surgery clinic, Chitose Shi, Hokkaido, Japan
🇯🇵
Takagi Dermatological Clinic, Obihiro, Hokkaido, Japan

and more 8 locations

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Completed

Conditions: Breast Cancer

First Posted Date: 2020-08-04

Last Posted Date: 2020-08-04

Lead Sponsor: Pfizer

Target Recruit Count: 1

Registration Number: NCT04498481

Locations: 🇺🇸
Pfizer United States, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy